greeksoup/ stock research

Incyte Corp. insider trading

In twelve months insiders at Incyte bought nothing and sold $57.4M on the open market; 45 of the 45 sales were under plans set months before.

Bought on the open marketNonein twelve months
Sold on the open market$57.4M45 sales
Sales set in advance45 of 45under Rule 10b5-1 plans
Pay taken in stock88 by own choice
New to this? How to read this page
  1. Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
  2. A purchase on the open market is the strongest sign: the insider spent their own money.
  3. A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
  4. Grants, option exercises and shares held back for tax are left out.
  5. What is a Form 4? · Form 4 codes

What kind of trades

Insiders only sold: 45 sales worth $57.4M, and 45 of them were under plans set months before, which say little.

Purchasebought with their own money
Pay in stock, own choiceowed cash, chose shares
Sale outside a planthe insider picked the day
Sale under a plandates fixed months before
Says littlecompany plans, board pay, cash units
Bought
8 pay by choice
Sold
45 under a plan

Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.

Insider trades on the share price

last twelve months

41 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.

PurchasePay in stock, own choiceSale outside a planSale under a planSays little

The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.

Trades worth a closer look

A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.

Who traded

dollars, twelve months

10 insiders traded. The most: Hoppenot Herve, sale under a plan $19.8M.

One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.

How it compares

every company on the site

Open-market sales, twelve months

Open-market purchases, twelve months

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every Form 4 line

    Purchase: bought on the open market with their own moneyTook pay in stock, own choice: owed cash, chose shares instead; a softer signSale: sold on the open market, not under a plan set in advanceSale, trading plan: under a Rule 10b5-1 plan set up months before, so the date was fixed in advanceGrey lines: plan purchases, pay in stock taken by the whole board or under a company plan, and units paid in cash; they say little about the insider's own view
    TradedInsiderRoleTypeSharesPriceValueFiling
    3 November 2026Tray ThomasPrincipal Accounting OfficerSaletrading plan set in advance · Form 144 notice 3 November 2026610$118.96$72,566Form 4
    15 October 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 15 October 20262,642$112.71$297,780Form 4
    30 September 2026Clancy Paul JDirectorTook pay in stockown choice203$121.35$24,634Form 4

    Took a $24,634 retainer as 203 shares instead of cash. The stock had risen 7% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    30 September 2026Harrigan EdmundDirectorTook pay in stockown choice206$121.35$24,998Form 4

    Took a $24,998 retainer as 206 shares instead of cash. The stock had risen 7% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    15 September 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 15 September 20269,233$120.50$1.1 millionForm 4
    15 September 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 15 September 202613,985$120.49$1.7 millionForm 4
    19 August 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 19 August 202610,801$125.56$1.4 millionForm 4
    12 August 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 12 August 202610,803$120.04$1.3 millionForm 4
    5 August 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 5 August 202610,640$122.69$1.3 millionForm 4
    5 August 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 5 August 20262,207$123.99$273,646Form 4
    3 August 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 3 August 20266,055$120.43$729,204Form 4
    31 July 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 31 July 202615,888$119.70$1.9 millionForm 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 202614,661$119.46$1.8 millionForm 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20265,332$119.42$636,747Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20262,187$119.47$261,281Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20266,171$119.43$737,003Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20264,695$119.39$560,536Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20262,864$119.40$341,962Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20261,643$119.51$196,355Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20261,642$119.38$196,022Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 202685$122.19$10,386Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 2026326$121.69$39,671Form 4
    31 July 2026Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 31 July 20262,293$119.41$273,807Form 4
    16 July 2026Stein Steven HCMO & Head of Late-Stage Dev.Saletrading plan set in advance · Form 144 notice 16 July 20261,877$114.73$215,348Form 4
    16 July 2026Issa Mohamed KhairieEVP, Head of U.S. CommercialSaletrading plan set in advance · Form 144 notice 16 July 20261,093$115.01$125,706Form 4
    15 July 2026Stein Steven HCMO & Head of Late-Stage Dev.Saletrading plan set in advance · Form 144 notice 16 July 202628,237$113.05$3.2 millionForm 4
    30 June 2026Clancy Paul JDirectorTook pay in stockown choice252$113.36$28,567Form 4

    Took a $28,567 retainer as 252 shares instead of cash. The stock had risen 20% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    30 June 2026Harrigan EdmundDirectorTook pay in stockown choice255$113.36$28,907Form 4

    Took a $28,907 retainer as 255 shares instead of cash. The stock had risen 20% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    4 June 2026Tray ThomasPrincipal Accounting OfficerSaletrading plan set in advance · Form 144 notice 4 June 20262,639$100.00$263,900Form 4
    26 May 2026Tray ThomasPrincipal Accounting OfficerSaletrading plan set in advance · Form 144 notice 26 May 20262,051$97.35$199,665Form 4
    19 May 2026Clancy Paul JDirectorSaletrading plan set in advance · Form 144 notice 19 May 202615,000$94.93$1.4 millionForm 4
    17 April 2026Cagnoni Pablo JPresident, Global Head of R&DSaletrading plan set in advance · Form 144 notice 17 April 202618,667$96.50$1.8 millionForm 4
    31 March 2026Harrigan EdmundDirectorTook pay in stockown choice269$94.12$25,318Form 4

    Took a $25,318 retainer as 269 shares instead of cash. The stock had fallen 5% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    31 March 2026Clancy Paul JDirectorTook pay in stockown choice265$94.12$24,942Form 4

    Took a $24,942 retainer as 265 shares instead of cash. The stock had fallen 5% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    17 March 2026Cagnoni Pablo JPresident, R&DSaletrading plan set in advance · Form 144 notice 17 March 202618,667$94.24$1.8 millionForm 4
    19 February 2026Cagnoni Pablo JPresident, R&DSaletrading plan set in advance · Form 144 notice 19 February 202618,668$100.91$1.9 millionForm 4
    7 January 2026Issa Mohamed KhairieEVP, Head of US OncologySaletrading plan set in advance · Form 144 notice 7 January 202610,856$109.07$1.2 millionForm 4
    5 January 2026Stein Steven HEVP & Chief Medical OfficerSaletrading plan set in advance · Form 144 notice 5 January 202615,634$101.70$1.6 millionForm 4
    31 December 2025Clancy Paul JDirectorTook pay in stockown choice241$98.77$23,804Form 4

    Took a $23,804 retainer as 241 shares instead of cash. The stock had risen 14% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    31 December 2025Harrigan EdmundDirectorTook pay in stockown choice245$98.77$24,199Form 4

    Took a $24,199 retainer as 245 shares instead of cash. The stock had risen 14% in the three months before.

    The filing's own wordsRestricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.Form 4 footnote, as filed
    19 December 2025Tray ThomasPrincipal Accounting OfficerSaletrading plan set in advance · Form 144 notice 19 December 20252,774$100.00$277,400Form 4
    18 December 2025Tray ThomasPrincipal Accounting OfficerSaletrading plan set in advance · Form 144 notice 19 December 2025600$98.25$58,950Form 4
    17 December 2025Morrissey Michael JamesEVP, Head of Tech. OperationsSaletrading plan set in advance · Form 144 notice 17 December 20254,323$97.26$420,455Form 4
    16 December 2025Morrissey Michael JamesEVP, Head of Tech. OperationsSaletrading plan set in advance · Form 144 notice 17 December 2025833$97.42$81,151Form 4
    16 December 2025Morrissey Michael JamesEVP, Head of Tech. OperationsSaletrading plan set in advance · Form 144 notice 17 December 202553,175$97.29$5.2 millionForm 4
    11 December 2025Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 11 December 2025255$94.94$24,210Form 4
    10 December 2025Mayes Patrick AEVP & Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 11 December 20255,553$95.58$530,756Form 4
    2 December 2025Stein Steven HEVP & Chief Medical OfficerSaletrading plan set in advance · Form 144 notice 2 December 202520,105$102.51$2.1 millionForm 4
    1 December 2025Stein Steven HEVP & Chief Medical OfficerSaletrading plan set in advance · Form 144 notice 2 December 20252,559$102.96$263,475Form 4
    24 November 2025Tray ThomasPrincipal Accounting OfficerSaletrading plan set in advance · Form 144 notice 24 November 2025600$103.00$61,800Form 4
    21 November 2025Tray ThomasPrincipal Accounting OfficerSaletrading plan set in advance · Form 144 notice 21 November 2025169$102.00$17,238Form 4
    17 November 2025Denton Sheila A.EVP & General CounselSaletrading plan set in advance · Form 144 notice 17 November 2025278$104.36$29,012Form 4
    10 November 2025Hoppenot HerveDirectorSaletrading plan set in advance · Form 144 notice 10 November 2025187,500$105.46$19.8 millionForm 4
    A filing with several lines appears once per line.
    Read morePay taken in stock by the insider's own choice has the filing's footnote, word for word, in the note under it; for the others, hold the pointer on the type. An award filed at no price shows n/a.